Thrombus

This item requires a subscription.

Should patients with venous thrombosis have cancer screening?
Thrombus, Volume 13, Number 1.

Ten per cent of patients with idiopathic venous thromboembolism (VTE) will have underlying occult malignancy, and there is a threefold increased risk of new cancer diagnosis in the months following VTE diagnosis.1–8 Where occult cancer is present, it is metastatic in 40–60% of cases. The issue of whether or not to screen patients with acute VTE for occult cancer at diagnosis is controversial, and there is no consensus on how extensive any screening programme should be. Few studies have addressed the cost, safety, psychological stress and health benefits associated with extensive screening strategies.

To view this item, select one of the options below:

	Purchase access
	In order to view articles you will need to pay a subscription for either 24-hour or annual access. You can view all articles on this site during the subscription period. Please click here to subscribe.

	Sign in
	If you are already have a subscription, please sign in here.
	email address
	Password
	Forgotten your password?

	Important
	All the articles are in PDF format.
	To view the articles you will need Adobe Acrobat Reader.
	To download a copy, free of charge, please click here.

	Help
	If you need help accessing this site, please click here.

The data, opinions and statements appearing in the articles herein are those of the contributor(s) concerned; they are not necessarily endorsed by the sponsors, publisher, Editor or Editorial Board. Accordingly the sponsors, publisher, Editor and Editorial Board and their respective employees, officers and agents accept no liability for the consequences of any such inaccurate or misleading data, opinion or statement.
Copyright (©) 2010 Hayward Group Ltd. The title Thrombus is the property of Hayward Group Ltd and, together with the content, is bound by copyright. The information contained on the site may not be reproduced, distributed or published, in whole or in part, in any form without the permission of the publishers. All correspondence should be addressed to: admin@hayward.co.uk